Posts

Psychedelic Business Spotlight – June 24

This Week in Psychedelic Stocks: Compass Pathways Wins Patent Battle, MindMed Patents Candy Flipping, and More!

, ,
This week in psychedelic stock news, there are big patent developments for Compass, MindMed and Numinus.
Psychedelic Business Spotlight - June 17

Psychedelic Business Spotlight – June 17

, ,
This week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin moves closer to clinical trials, and more!

Psychedelic Business Spotlight – June 10

,
This week in psychedelic business news: Cybin acquires a Phase 1 DMT trial from Entheon; Numinus completed the acquisition of Novamind, MindMed's stock is removed from an index; and...
5 Next-Generation Psychedelics Entering Clinical Trials This YearShutterstock

5 Next-Generation Psychedelics Entering Clinical Trials This Year

,
Modernized psychedelic medicine is coming, whether you like it or not, so here are five of the most exciting next-generation psychedelics on the horizon.
Why Wednesday Will Be Biggest Day for Psychedelic Investors of 2022Shutterstock

Why Wednesday Will Be Biggest Day of 2022 for Psychedelic Investors

,
Psychedelic investors are about to see pivotal data presented on flagship programs by the titans of the psychedelics industry.
Shutterstock

Elon Musk Excites Psychedelic Industry CEOs with This Tweet

,
This is one of the billionaire's most explicit acknowledgments of the power of psychedelics for mental health applications.
My Favorite Psychedelic Stocks Part 1Shutterstock

My Favorite Psychedelic Stocks: Part 1

,
Our resident Psychedelic Investor details five companies he thinks are in strong position to win the psychedelic medicine race.

Psychedelic Business Spotlight – February 18

,
This week in psychedelic business news: Nova Mentis makes progress on autism; atai donates to MAPS; Cathie Wood eyes more psychedelic stocks.
Cybin Partners with The Chopra Foundation to Bring Awareness to the Benefits of Psychedelic-Based TherapiesSponsored Content

Cybin Partners with The Chopra Foundation to Bring Awareness to the Benefits of Psychedelic-Based Therapies

"The need for new and more effective treatments across the mental health spectrum is more urgent today than ever," says Dr. Deepak Chopra.
Psychedelic Business Spotlight – February 11

Psychedelic Business Spotlight – February 11

,
This week in psychedelic business news: Cybin scores another patent; another huge psychedelics conference heads to Miami; Core One Labs widens pipeline with another drug.